Rapamycin reduces renal hypoxia, interstitial inflammation and fibrosis in a rat model of unilateral ureteral obstruction

Clinical and Investigative Medicine

Volumn 37, Issue 3, 2014, Pages 142-153

  Liu, Chun Feng ^a   Liu, Hing ^a   Fang, Yi ^a   Jiang, Su Hua ^a   Zhu, Jia Ming ^a   Ding, Xiao Qiang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLT1 PROTEIN, RAT; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN RECEPTOR 1;

ANIMAL; ANOXIA; COMPLICATION; FIBROSIS; GENETICS; KIDNEY DISEASES; MALE; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; URETER OBSTRUCTION; WESTERN BLOTTING;

ANIMALS; ANOXIA; BLOTTING, WESTERN; FIBROSIS; KIDNEY DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SIROLIMUS; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84902198902     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: 10.25011/cim.v37i3.21381     Document Type: Article

References (22)

1. Fine LG, Orphanides C, Norman JT. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int. suppl. 1998;65:S74-S78. PMID: 9551436
2. Fine LG, Norman JT. the breathing kidney. J. Am. Soc. Nephrol. 2002;13(7):1974-1976. PMID: 12089396
3. Bauer C, Kurtz A, Forefronts in nephrology meeting oxygen sensing on the cellular and molecular level, International Society of Nephrology (ISN). Forefronts in Nephrology: Oxygen sensing on the cellular and molecular level. Kidney Int. 1997;51:371-608.
4. Gleadle JM, Ebert BL, Firth JD, Ratcliffe PJ. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am. J. Physiol. 1995;268 (6 Pt 1):C1362-C1368. PMID: 7541940
5. Shih SC, Claffey KP. Hypoxia-mediated regulation of gene expression in mammalian cells. Int. J. Exp. Pathol. 1998;79(6):347-357. PMID: 10319016
6. Kwon TG, Zhao X, Yang Q, Li Y, Ge C, Zhao G, et al. Physical and functional interactions between Runx2 and HIF-1α induce vascular endothelial growth factor gene expression. J. Cell. Biochem. 2011;112(12):3582-3593. PMID: 21793044
7. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13(1):9-22. PMID: 9872925
8. Summers AM, Coupes BM, Brennan MF, Ralph SA, Short CD, Brenchley PE. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrol. Dial. Transplant 2005;20(11):2427-2432. PMID: 16046504
9. Schmelzle T, Hall MN. TOR a central controller of cell growth. Cell 2000;103(2): 253-262. PMID: 11057898
10. Kim MS, Park J, Ha H, Kim YS, Kang SW, Jeong HJ, et al. Rapamycin inhibits platelet-derived growth factor-induced collagen, but not fibronectin, synthesis in rat mesangial cells. Yonsei. Med. J. 2004;45(6):1121-1126. PMID: 15627306
11. Wang W, Chan YH, Lee W, Chan L. Effect of rapamycin and FK506 on mesangial cell proliferation. Transplant Proc. 2001;33(1-2):1036-1037. PMID: 11267180
12. Wu MJ, Wen MC, Chiu YT, Chiou YY, Shu KH, Tang MJ. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int. 2006;69(11):2029-2036. PMID: 16732193
13. Bonegio RG, Fuhro R, Wang Z, Valeri CR, Andry C, Salant DJ, et al. Rapamycin ameliorates roteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J. Am. Soc. Nephrol. 2005;16(7):2063-2072. PMID: 15917339
14. Giaccia A, Siim BG, Johnson RS. HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2003;2(10):803-811. PMID: 14526383
15. Ponticelli C. the pleiotropic effects of mTOR inhibitor. J. Nephrol. 2004;17(6):762-768. PMID: 15593048
16. Tamura K, Yoshie M, Miyajima E, Kano M, Tachikawa E. Stathmin Regulates Hypoxia-Inducible Factor-1α Expression through the Mammalian Target of Rapamycin Pathway in Ovarian Clear Cell Adenocarcinoma. ISRN Pharmacol. 2013;2013:279593. PMID: 23819061
17. Frost P, Berlanger E, Mysore V, Hoang B, Shi Y, Gera J, Lichtenstein A. Mammalian target of rapamycin inhibitors induce tumor cell apoptosis in vivo primarily by inhibiting VEGF expression and angiogenesis. J. Oncol. 2013;2013:897025. PMID: 23533410
18. Ko HT, Yin JL, Wyburn K, Wu H, Eris JM, Hambly BD, et al. Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction. Nephrol. Dial .Transplant. 2013;28(2):327-336. PMID: 23229928
19. De Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J. Am. Soc. Nephrol. 2001;12(5):993-1000. PMID: 11316858
20. Senthil D, Choudhury GG, McLaurin C, Kasinath BS. Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: A potential role in diabetic nephropathy. Kidney Int. 2003;64(2):468-479. PMID: 12846742
21. Suga S, Kim YG, Joly A, Puchacz E, Kang DH, Jefferson JA, et al. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int. 2001;60(4):1297-1308. PMID: 11576344
22. Fehr JE, Trotter GW, Oxford JT, Hart DA. Comparison of Northern blot hybridization and a reverse transcriptasepolymerase chain reaction technique for measurement of mRNA expression of metalloproteinases and matrix components in articular cartilage and synovial membrane from horses with osteoarthritis. Am J Vet Res. 2000; 61:900-905. PMID: 10951979